Europe - Euronext Amsterdam - AMS:EXO - NL0012059018 - Common Stock
We assign a fundamental rating of 4 out of 10 to EXO. EXO was compared to 59 industry peers in the Financial Services industry. EXO has a great financial health rating, but its profitability evaluates not so good. EXO has a expensive valuation and it also scores bad on growth.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.62% | ||
| ROE | -1.78% | ||
| ROIC | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | -5096.69% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 1.25 | ||
| Altman-Z | 3.71 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.21 | ||
| Quick Ratio | 2.21 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 36.17 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.21 | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.69% |
ChartMill assigns a fundamental rating of 4 / 10 to EXO.AS.
ChartMill assigns a valuation rating of 2 / 10 to EXOR NV (EXO.AS). This can be considered as Overvalued.
EXOR NV (EXO.AS) has a profitability rating of 3 / 10.
The financial health rating of EXOR NV (EXO.AS) is 8 / 10.